A possible explanation for this phenomenon is that AKT pathway alterations promote cell proliferation and survival, such that alterations are more likely to accumulate in such a selective pressure environment, and consequently, the tumor mutational burden may also remain high. The gene discussed is AKT1; the disease is neoplasm.